FeesSafety
Pluang+

Annovis Bio to present three studies on Alzheimer’s drug buntanetap at CTAD 2026 conference

Market News
22 Oct 2026
GlobeNewsWire
View Source
Bullish
Annovis Bio to present three studies on Alzheimer’s drug buntanetap at CTAD 2026 conference

Annovis Bio, a biotech company developing buntanetap for Alzheimer’s and Parkinson’s, will present three studies at the CTAD 2026 conference in Boston. The presentations cover buntanetap’s mechanism, clinical trial design, and AI use in drug evaluation. These updates highlight progress toward a pivotal Phase 3 data readout expected in early 2027 and preparations for a New Drug Application. This showcases Annovis’s advancing efforts in neurodegenerative disease treatment.

Annovis Bio's upcoming presentations at CTAD 2026 provide context for readers interested in biotech developments. For readers following the Health sector, here is Pluang's market snapshot as of Oct 22, 2026 19:13 WIB: Out of 150 priced Health-sector US stocks tradable on Pluang, 63 rose and 79 fell today. Notable movers include Quest Diagnostics Inc (DGX) at USD 229.99 with a 1-day change of -3.64% and a typical hold time on Pluang of 57 days, Summit Therapeutics Inc (SMMT) at USD 15.32 down 3.22%, and Medpace Holdings Inc (MEDP) at USD 642.01 down 3.09%, with typical hold times of 17 and 15 days respectively.

More News

Flutter Entertainment to release Q3 2026 update and hold conference call on Nov 4

Flutter Entertainment to release Q3 2026 update and hold conference call on Nov 4

Flutter Entertainment, a leading online sports betting and iGaming operator, will release its third quarter 2026 update on November 4 before the US market opens. The company will host a conference call at 8:30 a.m. ET the same day to discuss the resu...

Company Fundamentals
Neutral
51 minutes ago
iPower announces 1-for-12 reverse stock split to boost share price and maintain Nasdaq listing

iPower announces 1-for-12 reverse stock split to boost share price and maintain Nasdaq listing

iPower Inc. declared a 1-for-12 reverse stock split effective October 26, 2026, combining every 12 shares into one to increase the stock price. This move aims to keep iPower's shares compliant with Nasdaq's minimum bid price requirements. Post-split,...

Company Fundamentals
Neutral
51 minutes ago
U.S. Global Investors lists its WAR ETF on Lima Stock Exchange, expanding defense-tech access for Peruvian investors.

U.S. Global Investors lists its WAR ETF on Lima Stock Exchange, expanding defense-tech access for Peruvian investors.

U.S. Global Investors has listed its actively managed U.S. Global Technology and Aerospace & Defense ETF (WAR) on Peru's Lima Stock Exchange, marking the first availability of this ETF outside the U.S. This move gives Peruvian investors access to a f...

Market News
Bullish
51 minutes ago
Alignment Health adds new Medicare Advantage plan in Pima County for 2027, expanding coverage for Arizona seniors.

Alignment Health adds new Medicare Advantage plan in Pima County for 2027, expanding coverage for Arizona seniors.

Alignment Health Plan will launch a new Medicare Advantage plan in Pima County starting January 1, 2027, increasing access to affordable, coordinated healthcare for nearly 1.1 million Medicare beneficiaries across Maricopa, Pima, and Santa Cruz count...

Market News
Bullish
51 minutes ago
Urban Air Mobility market to hit $16.27B by 2035, driven by eVTOL tech and smart city growth

Urban Air Mobility market to hit $16.27B by 2035, driven by eVTOL tech and smart city growth

The global Urban Air Mobility (UAM) market is projected to grow from $2.16 billion in 2026 to $16.27 billion by 2035, at a CAGR of 20.9%. This growth is fueled by rising urbanization, traffic congestion, and advances in electric vertical takeoff and ...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App